Press Release
Why will Trump win the 2020 election?
When people think, God laughs. Trump will definitely win this election. No reason is needed, just believing. In order to avoid being labelled as a god-stick, I will talk about Eastern Zen Buddhism. When Master Bodhidharma taught the Dharma, he said that “no words are directed at people’s hearts”, pointing out that truth cannot be expressed in words, and what is expressed in words is not truth. The Diamond Sutra Buddha Shakyamuni also stated that the Buddha has never taught the real Dharma, and everything I say is not the righteous Dharma. Lao Tzu’s Tao Te Ching preaches, Tao can be very Tao, Tao is simple. Also said the unspeakable truth.
Let’s talk about the amazing experimental results of modern biology and neurology. After rigorous scientific experiments, experimental experts have discovered that the time for humans to act is before the thinking and decisions of the human brain. What does this mean? That is to say, before your brain makes a decision, your nerves command your body to act before your thinking and decision-making, but the time is so short that you can’t even notice it. Therefore, the destiny of human beings is predestined, and our brain’s thinking is only an explanation based on the results that we can understand and believe in our own behavior. In other words, we mistakenly believe that our destiny is the result of our own thinking and choices, not determined by karma and the Creator.
Therefore, I said that Trump will definitely win the 2020 election. It is a script written by God long ago. We just believe that there is no need to worry and worry. Wu Chengen, the author of Journey to the West, has a metaphor at the end of the book, that is, the Buddha recites in Tang Seng and his apprentices are not far away, and the sincerity of seeking the scriptures after hardships is commendable. At the beginning, the Tang Seng was given the Lingshan Supreme Treasure Without Words scripture, but Tang Seng discovered halfway through Later, he returned to the false scriptures, which was supposed to be a mockery of him. Finally, the Buddha lamented the dullness of the sentient beings in Nanchan Tribe, and gave Tang Seng the scriptures with words that he believed were true scriptures. As the saying goes, there must be chaos. As time goes by, the chaos of the age of human nature is degenerate, and this is the root of the chaos.
The above text is just as everyone is worried about Trump. Now, let’s make a joke with everyone and relax. Next, we will use the habit of giving reasons to believe and talk about why Trump will win the 2020 election.
First of all, in the 2020 election, Trump and Biden have both said that they won? So, is the truth important or Trump’s win?
It is more important than Trump’s win. If we think that as long as Trump can win us regardless of the truth, then Trump is just like Biden by all means to win. We are not worthy to support Trump. Therefore, we first believe that the truth is that Trump is the president elected by most Americans, and Biden’s subsequent overtake is the result of cheating.
The fact is also that all the states where Biden later overtook the bizarre number of votes than registered voters. Suddenly, there was no reason to stop counting votes. After a few hours, Biden was in a rocket-like lead; there were no more than 100,000 votes in the midnight ghost. Exceptions are Biden; countless people who have been dead for many years are voting; many voters are shown to be over 120 or even 170 years old; thousands of votes cast by Trump are found to be counted as Biden; democracy Party states violated regulations to prohibit Republican vote-taking inspectors from jointly scrutinizing votes; some states use the voting system produced by Pelosi’s companies, whether or not Trump’s votes are recorded as voting for Biden, and so on. Then according to many Statehouse synchronized elections member of Republican senators are leading Democrat victory over a dozen points, while in the same region Trump has lost Biden to analyze the phenomenon, in addition to the Democratic ballot fraud cheating In addition, the only explanation is that the local voters are schizophrenic. They voted for Republican congressmen, but they magically voted for the Democratic president.
Therefore, there are no waves without wind, and there must be demons in the abnormal. We have reason to believe the truth is that Trump significantly ahead of Biden, and actually 11 Yue 3 statutory election day has been fantastic, and then to begin the Democrats no bottom line in several key states, no scruples, unprincipled vote cheating Falsification has led to the current situation where Biden has overtaken and is almost winning, and this kind of vote falsification is a premeditated, well-prepared and widely organized behavior.
Then the current crisis so acute Biden and White House seems one step, one-sided mainstream media social software to Biden’s case, Trump win it? Yes, Trump will definitely win, he will enter the White House in 2021 , lead the United States, lead the world, and complete his unfinished business, and the four-year Trump term in the second term will be more exciting and more exciting than the first term. People are excited because Trump never disappoints his supporters and always gives more than expected. In the 2020 U.S. election, Trump will win and must win, because if Trump is cheated by the Biden Democratic Party this time, there will never be a future. This is the final battle. If we cannot defend our votes this time, there will be no votes that truly represent our will in the future.
Talk about three reasons Trump must win:
The first administrative judicial system to resolve disputes peacefully is beneficial to Trump
A major feature of democratic countries is that there are disputes that can be resolved peacefully instead of violence by relying on a trustworthy system. The separation of powers in the United States: Judiciary, Congress, and Administration. The number of Supreme Court justices is the absolute advantage of the Republican Party. Trump counts as one point; Congress Trump controls the Senate majority party as 0.5 points; Biden controls the House majority party as 0.5 points; the administration is controlled by Trump’s White House team and counts one point; if necessary If the mainstream media is considered the fourth right, then Biden is one point; the comparison is that Trump 2.5 points to Biden 1.5 points, and Trump is better than Biden in resolving disputes between the two sides of a normal procedure and peaceful gentleman.
The second people have the awareness and ability to defend the elected President Trump with arms
Trump’s Republican Party has always supported the American people’s right to own guns, while the Democrats are the opposite. Because Gong Huo Party Performed constitutional rationale idea is that the American people have the right to armed overthrow of tyranny, so people have the right gun. As the saying goes, there is a lingering fragrance in the hands of roses. Armed people also have the ability to defend their elected president. Most of the supporters of the Republican Party are voters with gun ideas and qualifications. Various militia organizations and firearms associations will hold weapons to deter all conspiracies that dare to use improper means to overthrow the elected president. In the face of such an armed people, any conspirator must be cautious when doing evil. The key is that the only possible participation of the armed forces police force is Trump’s staunch supporter, thanks to the Biden Democratic Party for supporting Antifa and other ultra-left organizations to mess up the United States to fish in troubled waters and long-term suppression of the police system. US military owned by the state is not involved in internal party strife, that decorum situation under conditions, Trump force values can be easily rolled Biden Democrats. To put it straightforwardly, Biden controls the American moneybags (Wall Street and big capitalists) and pens (mainstream media and high-tech companies), but Trump controls the American knives (police and armed people). If the Democratic Party can’t resolve the election disputes peacefully by playing a rogue, the knife is much easier to use than a purse and a pen.
Third, Trump’s Taoists help others to help themselves
One of the most critical factors for Trump to win is that Trump deserves this victory! He is a tough fighter who will never give up. In the face of even more sinister conspiracies and powerful enemies, as long as you don’t give up, someone will fight with you until you succeed. Trump has proven to us that he is a warrior who is more and more courageous until victory. The Biden Democrats are accustomed to conspiracy, but this time the bully found the wrong opponent and kicked it on the steel plate. The U.S. Supreme Court has intervened in the vote fraud case at Trump’s request; the U.S. Senate and the Republican Party have announced that they will stand with Trump under any circumstances; voters in 50 U.S. states have begun to take to the streets to support Trump and protect their President recapture the votes are represented by Democrat Joe Biden; large main American religious teachings explicitly called on all those who believe in God the United States (population accounted for 60% ) strongly supports Trump, is standing on the side of God against the sub-plot to reshape the world of darkness; There are also the jealous relatives of Trump’s first family from his wife to his son, daughter, and son-in-law, who have always given Trump spiritual and deed support that others cannot give.
The most important thing is in God and with Donald Trump, Trump with God and in the upper Di and with Donald Trump in. Many friends think that God’s blessing is just a blessing, but I think this is the fundamental factor that Trump must win, because apart from this, the rest are for people to understand and talk about, and this is the real reason. Friends, we ask ourselves why we support Trump? Is it for the benefit of policy or to make more money for yourself, or is it because you hate Biden? If it is not, it is because we want to see justice done, fairness upheld, truth can be announced, and freedom protected. We believe that Trump represents light and hope, and we support the production and generalization so that our children can live in a beautiful, fair and orderly world in the future, so please believe that our support for Trump is a blessed power. It comes from the original love of all things. So Trump will surely get God’s favor.
Why is Trump sure to win, because God is with Trump, the son of light, and all those who support Trump because of love!
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
INmune Bio Establishes Global Commercialization Framework for Ebstrocel™ Through Strategic Agreement with Uniphar
Boca Raton, Florida, October 21st, 2026, FinanceWire
INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a late-stage biotechnology company focused on inflammation and immunology, today announced that it has entered into a Master Services Agreement with Uniphar Durbin Ireland Limited (“Uniphar”) establishing a scalable framework to support international access, distribution and commercialization of Ebstrocel
, the Company’s allogeneic stromal cell therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB). INmune Bio initially intends to use the framework to pursue named-patient access in selected European countries and in the Middle East and North Africa (MENA), subject to applicable law and country-specific statements of work. The relationship may subsequently expand across Europe and other territories by mutual agreement.
The Company expects named-patient access to be an important component of its international commercialization strategy for Ebstrocel. Where permitted by local law and implemented through statements of work, this pathway may allow physicians to request Ebstrocel for individual eligible patients before local marketing approval or broad commercial availability.
The Uniphar framework is designed to provide the Company with scalable international commercial infrastructure, beginning with named-patient supply, and potentially expanding to broader commercial distribution as regulatory approvals, pricing and reimbursement are secured in individual countries. Depending on the services agreed in individual statements of work, Uniphar may support regulatory feasibility assessments, market access, product storage and distribution, healthcare-provider and treatment-site onboarding, order-to-cash services, medical information, pharmacovigilance support and end-to-end shipment tracking. By leveraging Uniphar’s established infrastructure rather than building country-by-country capabilities internally, the Company believes this model provides a capital-efficient path to establish Ebstrocel’s international commercial footprint and scale as additional markets become available.
“This agreement marks an important step in moving Ebstrocel
“We are pleased to partner with INmune Bio as it prepares Ebstrocel for international commercialization,” said Ruth Rostron, Head of Expanded Access at Uniphar. “Uniphar has built an integrated global platform to help innovative medicines navigate the complexities of international access, distribution and commercialization. We believe our infrastructure and experience are well suited to support INmune Bio’s strategy for Ebstrocel, beginning with named-patient access opportunities and expanding as the product progresses through its regulatory and commercial journey.”
About Ebstrocel
Ebstrocel (pobistrocel) is INmune Bio’s investigational, pooled, allogeneic, human umbilical cord-derived mesenchymal stromal cell therapy being developed through the Company’s CORDStrom platform for the treatment of RDEB. The platform is designed to address donor variability and manufacturing inconsistency. Ebstrocel is investigational and has not been approved by the FDA, MHRA, EMA or any other regulatory authority.
About Uniphar Plc.
Uniphar is a trusted global partner to pharma, medtech and biotech, delivering solutions that connect medicines and technologies with patients worldwide. With over 57 years of experience and partnerships with 200+ multinational clients, Uniphar combines deep expertise, global infrastructure and market insight to meet the evolving needs of the life sciences sector.
Uniphar Pharma integrates Development, Clinical, Access, Medical, Commercial, Distribution and Global Sourcing to support the full product lifecycle – from early-stage research through to commercialization and beyond. Uniphar’s unified platform spans regulatory strategy, clinical trial support, medical affairs, market access, patient engagement, commercial services, distribution and supply chain.
Operating across 160 countries with a global team of 3,600+, Uniphar bridges manufacturers, healthcare providers, and patients — accelerating access to innovative therapies, improving patient outcomes, and delivering value across the healthcare ecosystem.
From molecule to market and beyond.
For more information, please visit www.uniphar.com
About INmune Bio Inc.
INmune Bio Inc. is a publicly traded (NASDAQ: INMB), late-stage biotechnology company focused on developing treatments that target the innate immune system to fight disease. Moving beyond early-stage exploration, the Company’s clinical-development strategy centers on advanced precision medicine, matching drug mechanisms directly to patient biology to optimize clinical outcomes.
INmune Bio is actively advancing two late-stage product platforms toward registrational milestones:
- CORDStrom: A proprietary, pooled, allogeneic, human umbilical cord-derived mesenchymal stromal cell platform engineered to address the historical clinical challenges of donor variability and manufacturing inconsistency. Following successful clinical readouts in RDEB, the platform is transitioning toward regulatory and commercial readiness, with an MAA planned for the UK MHRA in 2026 and EU EMA in 2027, alongside a planned U.S. regulatory pathway and development of international access and distribution infrastructure.
- XPro1595: A Dominant-Negative Tumor Necrosis Factor (DN-TNF) platform that selectively neutralizes soluble TNF (sTNF) to reduce pathological neuroinflammation without compromising protective immune function. Backed by recently granted FDA Fast Track designation and successful regulatory alignment from an End-of-Phase 2 meeting, XPro1595 is positioned for an integrated Phase 2b/3 seamless adaptive registrational program in neuroinflammation-enriched early Alzheimer’s disease.
To learn more about INmune Bio’s pipeline and its approach to harnessing the innate immune system, please visit www.inmunebio.com.
Forward Looking Statements
The Company’s product candidates are investigational, and there can be no assurance that any clinical, regulatory or commercial objective will be achieved. Any statements contained in this press release related to the development or commercialization of product candidates and other business and financial matters, including without limitation, trial results and data, timing of key milestones, future plans or expectations, the scope and implementation of the Uniphar relationship, the execution of statements of work, the availability and timing of named-patient or expanded-access sales, potential revenue, potential expansion across Europe or into Latin America, the anticipated capital efficiency of the distribution model, and the prospects for receiving regulatory approval or commercializing or selling any product or drug candidates, may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations but are subject to several risks and uncertainties. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements because of these risks and uncertainties. CORDStrom (EbstrocelTM, pobistrocel), XPro1595 (XPro, pegipanermin), and INKmune have either finished clinical trials, are still in clinical trials or are preparing to start clinical trials and have not been approved by the US Food and Drug Administration (FDA), the UK MHRA or any regulatory body and there cannot be any assurance that they will be approved by the FDA, the UK MHRA or any regulatory body or that any specific results will be achieved. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company’s ability to produce more drug for clinical trials; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, clinical studies and future product commercialization; and the Company’s business, research, product development, regulatory approval, marketing and distribution plans and strategies. These and other factors are identified and described in more detail in the Company’s filings with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K, the Company’s Quarterly Reports on Form 10-Q and the Company’s Current Reports on Form 8-K. The Company assumes no obligation to update any forward-looking statements to reflect any event or circumstance that may arise after the date of this release.
INmune Bio Contacts:
David Moss
Chief Executive Officer
(561) 710-0512
Daniel Carlson
Head of Investor Relations
(415) 509-4590
Uniphar Contacts:
Media Contacts:
Uniphar: Heather.Hopkin@teamtala.com and Beth.Oshea@teamtala.com
Contact
Uniphar
NPS_Ebstrocel@uniphar.com
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Warnickshire, UK, October 21st, 2026, FinanceWire
Data Accounting Highlights Its Approach to Financial Investigations and Announces International Expansion and AI Assistant Launch
Supporting financial transparency through forensic accounting, cross-border financial analysis, and assistance for individuals affected by financial losses.
Data Accounting continues to develop its capabilities in financial analysis, forensic accounting, and international compliance, helping businesses and individuals navigate complex financial situations.
As part of its international development strategy, Data Accounting is preparing to expand its presence across the United Arab Emirates, Australia and Singapore in late 2026 and early 2027. The planned expansion reflects the firm’s intention to broaden its international reach and support individuals and businesses dealing with complex financial matters across different jurisdictions.
Alongside this expansion, Data Accounting is developing a new AI-powered assistant, scheduled for launch in the first quarter of 2027. The assistant is intended to help individuals who have suffered financial losses, including those arising from potentially unsuitable financial advice or unclear regulatory processes, identify the nature of their concerns, organize relevant information and prepare their cases for review by Data Accounting’s team. The initiative aims to make the initial assessment process more accessible and help individuals understand what information may be relevant to their circumstances.
As financial transactions become increasingly international, the need for accurate documentation, reliable financial records, and effective oversight continues to grow. Data Accounting focuses on examining financial information, reviewing transaction histories, and identifying inconsistencies that may require further investigation or clarification.
Its work encompasses the analysis of financial statements, accounting documentation, tax-related records, and cross-border fund movements. Through structured review procedures and analytical techniques, the firm aims to help identify discrepancies, improve financial transparency, and support informed decision-making.
Forensic accounting can play an important role in understanding unusual transaction patterns, assessing the completeness of financial records, and identifying potential weaknesses in accounting or compliance procedures. Where concerns arise, a systematic examination of the available evidence can help clarify the circumstances and determine whether further professional or legal review may be appropriate.
Financial Support for Businesses and Individuals
Financial difficulties can affect both businesses and private individuals. In particular, individuals who have suffered financial losses may face uncertainty when trying to understand what happened, establish the status of their funds, or determine what options may be available to them.
Data Accounting aims to assist individuals affected by financial losses by helping them review relevant financial documentation, organize transaction records, and examine the circumstances surrounding their cases. This includes cases in which individuals have concerns about financial advice they received or difficulties understanding regulatory processes. Depending on the situation, this work may help identify discrepancies, clarify the movement of funds, and establish a clearer picture of the available evidence.
The planned AI assistant will provide an additional starting point for individuals seeking to explain their circumstances and organize information for assessment by the firm’s team. Each case will require an individual review, and potential next steps will depend on the circumstances, the documentation available, and the relevant legal and regulatory framework. Where appropriate, individuals may need to seek independent legal advice or contact the relevant financial institution or competent authority.
For businesses, sound financial oversight remains equally important. Companies operating across borders often manage international suppliers, overseas payments, multi-country payroll arrangements, and complex tax obligations. Weak documentation or inadequate internal controls can create financial uncertainty, operational difficulties, and compliance risks.
Data Accounting supports businesses seeking assistance with international accounting, tax advisory, financial reviews, and administrative processes. Its approach emphasizes accurate record-keeping, structured analysis, and the identification of potential weaknesses that may benefit from further attention.
Supporting Transparency Through Financial Analysis
Financial investigations require attention to detail, a methodical approach to evidence, and a clear understanding of accounting principles and applicable compliance requirements.
Data Accounting’s services focus on helping clients assess financial information, examine unusual transaction patterns, and obtain greater clarity regarding accounting and administrative matters. Depending on the circumstances and the scope of an engagement, this work may support internal reviews, financial assessments, or further independent professional examination.
By helping clients organize documentation and understand complex financial information, the firm seeks to support more informed decisions and improved financial accountability.
The planned international expansion and AI assistant launch represent further steps in Data Accounting’s development, combining its existing financial analysis capabilities with new ways for individuals and businesses to engage with the firm.
About Data Accounting
Data Accounting provides financial and accounting-related services for businesses and individuals seeking greater clarity and transparency in financial matters. Its areas of focus include international accounting, tax advisory, financial analysis, administrative support, and forensic accounting-related reviews.
The firm aims to help clients understand complex financial information, improve documentation practices, examine financial discrepancies, and identify opportunities to strengthen accounting and compliance procedures.
For more information about Data Accounting and its services, visit https://data-accounting.com/.
Contact
Jackie Cox
Data Accounting
reception@mail-data-accounting.com
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Saudi Arabia, 21st Oct 2026, Grand Newswire – Saudi digital content creator Nawaf Alzahrani has officially launched his personal blog, marking a new step in his digital media presence and providing a dedicated platform for sharing updates, exclusive releases, and project announcements.
The new blog aims to strengthen Alzahrani’s online presence by offering readers a central destination for following his work, exploring project developments, and accessing new digital content.
A New Platform for Exclusive Content
Alzahrani’s official blog is designed to serve as an editorial platform for project coverage, specialized insights, and direct updates. The initiative creates an additional channel through which audiences can stay informed about his activities and upcoming releases.
By launching a dedicated blog, Alzahrani is expanding his digital publishing presence and establishing a platform to support his long-term development goals.
A Vision for Future Growth
Commenting on the launch, Alzahrani emphasized his ambitions for the future and the role of the new platform in supporting his broader vision.
“Launching this platform provides a structured environment to support our future growth and deliver higher-value content to our community,” Alzahrani stated.
The blog reflects his commitment to developing new ways to share content, communicate updates, and build stronger connections with his audience.
Upcoming Releases and Updates
The official blog is now live and open to the public. A series of digital releases and special updates is scheduled for publication in the coming period.
Readers can visit the platform to follow future announcements and discover updates about Alzahrani’s projects as new content becomes available.
About Nawaf Alzahrani
Nawaf Alzahrani is a Saudi digital content creator. Channel owner H2rfez fM and a blog News Shop His newly launched personal blog provides a dedicated online platform for project updates, digital releases, specialized insights, and announcements about his work.
Media Contact
Organization: H2rfez fM
Contact
Person: Nawaf Alzahrani
Website:
https://smarline.ne
Email:
H2rfez1@gmail.com
Country:Saudi Arabia
The post Saudi Content Creator Nawaf Alzahrani Launches Official Blog
appeared first on Grand Newswire.
It is provided by a third-party content provider. Grand Newswire makes no
warranties or representations in connection with it.
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Saudi Content Creator Nawaf Alzahrani Launches Official Blog
Data Accounting Selected in 2026 to Conduct Financial Audits in EU
INmune Bio Establishes Global Commercialization Framework for Ebstrocel™ Through Strategic Agreement with Uniphar
Benzinga Money Article Discusses How to Become Part of the 12% of Retirees Who Have Achieved the Recommended $550,000 Minimum Retirement Savings Threshold
Apu Apustaja Conquers New York with Lively Street Ads, Including Times Square Billboard
Bay Smokes Maintains Quality Amid Legislative Changes in the Hemp Industry
-
Press Release5 days ago
Midwest Ragdolls Highlights Why a Kitten’s Early Environment Matters
-
Press Release1 week ago
INmune Bio Inc. and Quantum Computing Inc. Partner to Apply Quantum Optimization and AI to Advance Alzheimer’s Drug Research and Explore New Applications for XPro
-
Press Release4 days ago
From Karmayogi to the World Stage: Dr. Hemant Garg Wins “Excellence in AI for Public Policy”, Charts India’s Path to the AI Big League
-
Press Release1 week ago
Kira AI Launches AI Workspace that Thinks and Acts Across Everything Users Do, Say, and Decide
-
Press Release6 days ago
Exhibit at CES 2027: Showcasing GENCHI, the Immersive Avatar Service Called Crazy by a U.S. Angel Investor
-
Press Release1 week ago
Evolution Metals & Technologies Corp. Reaffirms $400 Million to $460 Million FY2027 Revenue Guidance, Unveils Eight Sintered Magnet Grades Covering an Estimated 75% of Global NdFeB Revenue, and Moves to Answer U.S. Army Call for Rare Earth Magnets
-
Press Release4 days ago
U-topia Launches Public Beta as Global Builders Gather for U-Hackathon
-
Press Release4 days ago
Karviva and Founder Dr. Angela Zeng Featured in 2026 USA TODAY Food as Medicine Edition.